More rapid detection of unwanted microbes in food
27 June, 2007
The genomics revolution is helping food scientists to better predict microbial presence and possible toxin production as well as respond more rapidly should a food calamity occur, according to Professor Stanley Brul, University of Amsterdam.
Embryonic stem cells
26 June, 2007
Researchers at Children’s Hospital Boston have reported a new and efficient strategy, using eggs alone, for creating mouse embryonic stem cells that can be transplanted without the risk of rejection because the cells are compatible with the recipient’s immune system.
Blood test to spot TB in children
21 June, 2007
Accurate tuberculosis testing in children is crucial as the disease can rapidly spread from the lungs to other organs, leading to life-threatening conditions which particularly affect children. A simple blood test to analyse and identify proteins circulating in the blood of infected children could provide the answer.
A vaccine for nicotine addiction
20 June, 2007
Cytos Biotechnology has announced that it has entered into an exclusive global commercial licence agreement with Novartis to develop, manufacture and commercialise CYT002-NicQb, a therapeutic vaccine in phase II clinical development for the treatment of nicotine addiction.
Transdermal vaccine delivery
19 June, 2007
Apollo Life Sciences has announced it has successfully delivered a vaccine without needles, by applying it topically to the skin of mice using the company’s transdermal delivery technology. The technology could spell the end of injections for tetanus, flu and many other vaccine, according to Apollo’s CEO, John Priest.
Sequencing the Eucalyptus
12 June, 2007
The US Department of Energy Joint Genome Institute (DOE JGI) has announced its latest community sequencing programs.
Protein and peptide analysis
08 June, 2007 | Supplied by: Thermo Fisher Scientific
The Thermo Fisher Scientific LTQ XL linear ion trap mass spectrometer is equipped with electron transfer dissociation (ETD).
Haematology systems
08 June, 2007 | Supplied by: Beckman Coulter Australia
Beckman Coulter has introduced Coulter LH 780 haematology systems - top-of-the-line analysers that incorporate advancements to the company's VCS (volume, conductivity and scatter) technology for high sensitivity, specificity and efficiency in WBC differential analysis. The systems deliver functionality that increases laboratory capability and helps reduce healthcare costs.
Antibody array
08 June, 2007 | Supplied by: Merck
The Panorama Antibody Microarray XPRESS Profiler725 is a high-throughput tool for multiplex protein expression profiling of serum, cell or tissue extracts.
Rapid, high-yield protein production
08 June, 2007 | Supplied by: http://www.invitrogen.com/
The FreeStyle MAX System is a breakthrough technology for rapid and high-yield mammalian protein production.
Microarray scanner
09 May, 2007 | Supplied by: Molecular Devices
The GenePix family of microarray scanners has been expanded with the GenePix Professional 4200A scanner.
Genomic technology provides footrot breakthrough
30 April, 2007
Footrot in sheep may become a disease of the past thanks to research developed collaboratively between scientists at Monash University and The Institute for Genomic Research (TIGR) in Maryland, USA.
Blood test to diagnose Parkinson's
27 April, 2007
A simple test to diagnose Parkinson's disease (PD) before symptoms appear by measuring the levels of a protein in blood is being developed by researchers from the Howard Florey Institute, The University of Melbourne and The Mental Health Research Institute of Victoria.
Robotic microbiological instrumentation license agreement signed
20 April, 2007
LabTech Systems and bioMérieux have announced that they have signed an exclusive worldwide license agreement for LabTech Systems’ automated pre-poured media (PPM) streaker known as MicroStreak.
Clostridium in faeces
04 April, 2007 | Supplied by: Ngaio Diagnostics
The BioStar OIA CdTOX AB assay is an immunoassay test for the rapid qualitative detection of Clostridium difficile Toxins A and/or B in human faecal samples from patients suspected of having CDAD. Toxin A is an enterotoxin which appears to be responsible for the clinical symptoms of diarrhoea and colonic inflammation, while Toxin B is responsible for the associated cell destruction. Clinical symptoms of CDAD were once thought to be solely due to Toxin A; however, there is growing evidence that Toxin B may also play an important role in the pathogenesis of C. difficile. In many markets it is mandatory to use a test that detects both toxins, therefore a test which detects both toxins would be an aid to prompt diagnosis and allow the physician to initiate appropriate patient management.
